D-1056-2019 Class II Terminated
FDA drug recall D-1056-2019 was initiated by Allergan Sales, LLC on Mar 19, 2019 and is designated Class II. Reason for recall: cGMP Deviations The recall status is terminated (terminated Apr 29, 2020). Affected quantity: 72 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Apr 3, 2019
- Initiation Date
- Mar 19, 2019
- Termination Date
- Apr 29, 2020
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 72 bottles
Product description
Combigan (brimonidine tartrate/timolol maleate ophthalmic solution) 0.2%/0.5% 5 mL bottles, Rx only, Allergan, Inc. Irvine, CA 92612 U.S.A. NDC 0023-9211-05
Reason for recall
cGMP Deviations
Distribution pattern
TN only
Code information
Lot#: 99946 Exp. January 16, 2021
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1056-2019
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026